Use of Scandinavian Moist Smokeless Tobacco (Snus) and the Risk of Atrial Fibrillation.

Research output: Contribution to journalArticle

Abstract

Snus is a smokeless tobacco product, widely used among Swedish men and increasingly so elsewhere. There is debate as to whether snus is an acceptable "harm-reduction" tobacco product. Since snus use delivers a dose of nicotine equivalent to cigarettes, and has been implicated in cardiac arrhythmia because of associations with sudden cardiovascular death, a relation with atrial fibrillation is plausible and important to investigate.

Details

Authors
  • Maria-Pia Hergens
  • Rosaria Galanti
  • Jenny Hansson
  • Peeter Fredlund
  • Anders Ahlbom
  • Lars Alfredsson
  • Rino Bellocco
  • Marie Eriksson
  • Eleonor I Fransson
  • Johan Hallqvist
  • Jan-Håkan Jansson
  • Anders Knutsson
  • Nancy Pedersen
  • Ylva Trolle Lagerros
  • Per-Olof Östergren
  • Cecilia Magnusson
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Public Health, Global Health, Social Medicine and Epidemiology
Original languageEnglish
Pages (from-to)872-876
JournalEpidemiology
Volume25
Issue number6
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes